DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CASTOR OIL
2
Small molecule
Investigational
Unknown
Unknown
Premature Birth; Constipation
Unknown
CASTOR OIL
×
Maximum Phase:
2
First Approval:
None
UNII:
D5340Y2I9G
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLORINAB
2
Small molecule
Investigational
Unknown
Unknown
Abdominal Pain; Crohn Disease; Irritable Bowel Syndrome
Cannabinoid CB2 receptor agonist
OLORINAB
×
Maximum Phase:
2
First Approval:
None
UNII:
581F7DFA9B
Molecule Type:
Small molecule
Molecular Formula:
C18H23N5O3
Molecular Weight:
357.41
AlogP:
0.7
PSA:
106.98
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PLECONARIL
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Sepsis; Virus Diseases
VP1 capsid protein disrupting agent
PLECONARIL
×
Maximum Phase:
2
First Approval:
None
UNII:
9H4570Q89D
Molecule Type:
Small molecule
Molecular Formula:
C18H18F3N3O3
Molecular Weight:
381.35
AlogP:
4.68
PSA:
74.18
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DERSALAZINE SODIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DERSALAZINE SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STI-3031
2
Unknown
Investigational
Unknown
Unknown
Granuloma, Lethal Midline; Neoplasms
Unknown
STI-3031
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LICOGLIFLOZIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Kidney Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polycystic Ovary Syndrome
Sodium/glucose cotransporter 1 inhibitor
LICOGLIFLOZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
57J06X6EI0
Molecule Type:
Small molecule
Molecular Formula:
C23H28O7
Molecular Weight:
416.47
AlogP:
1.13
PSA:
108.61
HBD:
4.0
HBA:
#RotB:
5.0
Source:
SER-100
2
Protein
Investigational
Unknown
Unknown
Hypertension
Unknown
SER-100
×
Maximum Phase:
2
First Approval:
None
UNII:
VJ98TJ922K
Molecule Type:
Protein
Molecular Formula:
C85H141N27O15
Molecular Weight:
1781.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PRX-03140
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Serotonin 4 (5-HT4) receptor partial agonist
PRX-03140
×
Maximum Phase:
2
First Approval:
None
UNII:
7QGN8QXG7I
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O3S
Molecular Weight:
377.51
AlogP:
2.96
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TNT-1B
2
Antibody
Investigational
Unknown
Unknown
Glioblastoma
DNA-histone H1 complex binding agent
TNT-1B
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AXP-107-11
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma
Unknown
AXP-107-11
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HUMAX-IL8
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Severe Acute Respiratory Syndrome
Interleukin-8 inhibitor
HUMAX-IL8
×
Maximum Phase:
2
First Approval:
None
UNII:
N0YWS8X3S9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IN
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFLORNITHINE HCL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EFLORNITHINE HCL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AK104
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AK104
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEBENTAN
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Endothelin receptor ET-A antagonist
NEBENTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
IJ670B0H4A
Molecule Type:
Small molecule
Molecular Formula:
C24H21N5O5S
Molecular Weight:
491.53
AlogP:
4.16
PSA:
125.42
HBD:
1.0
HBA:
#RotB:
9.0
Source:
CPG-52852
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Melanoma
Toll-like receptor 7 agonist
CPG-52852
×
Maximum Phase:
2
First Approval:
None
UNII:
6PJC3KPK6S
Molecule Type:
Small molecule
Molecular Formula:
C17H23N5O2S
Molecular Weight:
361.47
AlogP:
2.06
PSA:
102.9
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CXL-1020
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Unknown
CXL-1020
×
Maximum Phase:
2
First Approval:
None
UNII:
T7Q0XY74OK
Molecule Type:
Small molecule
Molecular Formula:
C7H9NO5S2
Molecular Weight:
251.28
AlogP:
-0.24
PSA:
100.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DANUSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase Aurora inhibitor
DANUSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
M3X659D0FY
Molecule Type:
Small molecule
Molecular Formula:
C26H30N6O3
Molecular Weight:
474.57
AlogP:
2.64
PSA:
93.8
HBD:
2.0
HBA:
#RotB:
6.0
Source:
OMS405
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
OMS405
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPETIRIMOD ESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPETIRIMOD ESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H92K6N217F
Molecule Type:
Small molecule
Molecular Formula:
C15H23N5O4S
Molecular Weight:
369.45
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BXT-51072
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BXT-51072
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPB-348
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPB-348
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN
2
Enzyme
Investigational
Unknown
Unknown
Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell
Unknown
INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN
×
Maximum Phase:
2
First Approval:
None
UNII:
S8GQZ8LF0D
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VALZIFLOCEPT
2
Protein
Investigational
Unknown
Unknown
Glomerulonephritis, IGA
Unknown
VALZIFLOCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
EA2075XV4Y
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRX-2
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Breast Neoplasms; Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Squamous Intraepithelial Lesions
Unknown
IRX-2
×
Maximum Phase:
2
First Approval:
None
UNII:
ZDR4QSJ43F
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBATOCLAX
2
Small molecule
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma; Leukemia, Myeloid, Acute
Unknown
OBATOCLAX
×
Maximum Phase:
2
First Approval:
None
UNII:
QN4128B52A
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O
Molecular Weight:
317.39
AlogP:
4.49
PSA:
53.17
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BFH-772
2
Small molecule
Investigational
Unknown
Unknown
Rosacea
Unknown
BFH-772
×
Maximum Phase:
2
First Approval:
None
UNII:
T1IV236CVP
Molecule Type:
Small molecule
Molecular Formula:
C23H16F3N3O3
Molecular Weight:
439.39
AlogP:
5.19
PSA:
84.34
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FAPI GA-68
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FAPI GA-68
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C40H53GaN10O10
Molecular Weight:
903.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
M-1095
2
Unknown
Investigational
Unknown
Unknown
Psoriasis
Interleukin 17A inhibitor
M-1095
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BERUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
BERUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
6QPN83HK2M
Molecule Type:
Small molecule
Molecular Formula:
C34H35NO11
Molecular Weight:
633.65
AlogP:
2.23
PSA:
195.07
HBD:
5.0
HBA:
#RotB:
8.0
Source:
ATIPRIMOD
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Carcinoma, Neuroendocrine
Unknown
ATIPRIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
MG7D3QD743
Molecule Type:
Small molecule
Molecular Formula:
C22H44N2
Molecular Weight:
336.61
AlogP:
5.57
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
10.0
Source:
BVT.115959
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Adenosine A2a receptor agonist
BVT.115959
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NNC0114-0006
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1
Interleukin-21 binding agent
NNC0114-0006
×
Maximum Phase:
2
First Approval:
None
UNII:
L1SQ55DADE
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BELAPECTIN
2
Unknown
Investigational
Unknown
Unknown
Liver Diseases; Melanoma; Hypertension, Portal; Non-alcoholic Fatty Liver Disease; Psoriasis
Galectin-3 inhibitor
BELAPECTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
K7ODU55HT6
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOR03087
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MOR03087
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
168
169
170
171
172
173
174
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA